-
Original Article
-
Korean J Med. 2008;75(5):564-568.
- 증례: 알벤다졸(400 mg) 1회 복용에 의해 유발된 급성 독성간염 1예
-
김민관.박혜원.김원진.박철민.홍지연.조성진.장명국 , , , , , ,
-
- A case of acute drug-induced hepatotoxicity after albendazole treatment
-
Min Kwan Kim, Hye Won Park, Won Jin Kim, Chul Min Park, Ji Yeon Hong, Seung Jin Cho, Myoung Kuk Jang
-
경희대학교 의과대학 순환기내과학교실
-
- Abstract
- Drug-induced hepatotoxicity is injury to the liver as a result of drug exposure. Due to their unpredictable nature, drug-induced liver injuries pose a serious problem for clinicians, health agencies, and pharmaceutical firms. Albendazole is a benzimidazole with wide spectrum coverage as an antiparasitic drug. Very few cases of high-dose albendazole- induced hepatotoxicity have been reported so far, and no case in response to a single dose. A 25-year-old man presented to our hospital with dark urine. Twenty days prior to presentation, he took a tablet of albendazole (400 mg) as a prophylactic treatment for lumbricosis. Upon laboratory analysis, aspartate aminotransferase (AST) was 748 IU/L, alanine transaminase (ALT) was 939 IU/L, and total/direct bilirubin was 9.3/7.3 mg/dL. The patient was negative for viral markers (HAV, HBV, and HCV) and autoantibodies. Abdominal ultrasonography revealed no evidence of chronic liver damage. The pathology was compatible with drug-induced hepatotoxicity. The patient improved with conservative management only. (Korean J Med 75:564-568, 2008)
Keywords :Albendazole, Hepatotoxicity
